Literature DB >> 35576352

Postpartum Follow-up Care for Pregnant Persons With Opioid Use Disorder and Hepatitis C Virus Infection.

Marian Jarlenski1, Qingwen Chen, Katherine A Ahrens, Lindsay Allen, Anna E Austin, Catherine Chappell, Julie M Donohue, Lindsay Hammerslag, Paul Lanier, Mary Joan McDuffie, Jeffrey Talbert, Lu Tang, Elizabeth E Krans.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35576352      PMCID: PMC9170182          DOI: 10.1097/AOG.0000000000004760

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


× No keyword cloud information.
  11 in total

Review 1.  Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.

Authors:  Elizabeth E Krans; Stephen W Patrick
Journal:  Obstet Gynecol       Date:  2016-07       Impact factor: 7.661

2.  Estimating predicted probabilities from logistic regression: different methods correspond to different target populations.

Authors:  Clemma J Muller; Richard F MacLehose
Journal:  Int J Epidemiol       Date:  2014-03-05       Impact factor: 7.196

3.  Racism and Health: Evidence and Needed Research.

Authors:  David R Williams; Jourdyn A Lawrence; Brigette A Davis
Journal:  Annu Rev Public Health       Date:  2019-02-02       Impact factor: 21.981

4.  Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.

Authors:  Kathleen N Ly; Ruth B Jiles; Eyasu H Teshale; Monique A Foster; Rick L Pesano; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2017-05-09       Impact factor: 25.391

5.  A basic introduction to fixed-effect and random-effects models for meta-analysis.

Authors:  Michael Borenstein; Larry V Hedges; Julian P T Higgins; Hannah R Rothstein
Journal:  Res Synth Methods       Date:  2010-11-21       Impact factor: 5.273

6.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

7.  Innovative Solutions for State Medicaid Programs to Leverage Their Data, Build Their Analytic Capacity, and Create Evidence-Based Policy.

Authors:  Lauren Adams; Susan Kennedy; Lindsay Allen; Andrew Barnes; Tom Bias; Dushka Crane; Paul Lanier; Rachel Mauk; Shamis Mohamoud; Nathan Pauly; Jeffrey Talbert; Cynthia Woodcock; Kara Zivin; Julie Donohue
Journal:  EGEMS (Wash DC)       Date:  2019-08-05

8.  Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.

Authors:  Julie M Donohue; Marian P Jarlenski; Joo Yeon Kim; Lu Tang; Katherine Ahrens; Lindsay Allen; Anna Austin; Andrew J Barnes; Marguerite Burns; Chung-Chou H Chang; Sarah Clark; Evan Cole; Dushka Crane; Peter Cunningham; David Idala; Stefanie Junker; Paul Lanier; Rachel Mauk; Mary Joan McDuffie; Shamis Mohamoud; Nathan Pauly; Logan Sheets; Jeffery Talbert; Kara Zivin; Adam J Gordon; Susan Kennedy
Journal:  JAMA       Date:  2021-07-13       Impact factor: 56.272

9.  Healthcare Patterns of Pregnant Women and Children Affected by OUD in 9 State Medicaid Populations.

Authors:  Marian Jarlenski; Joo Yeon Kim; Katherine A Ahrens; Lindsay Allen; Anna Austin; Andrew J Barnes; Dushka Crane; Paul Lanier; Rachel Mauk; Shamis Mohamoud; Nathan Pauly; Jeffrey Talbert; Kara Zivin; Julie M Donohue
Journal:  J Addict Med       Date:  2021 Sep-Oct 01       Impact factor: 3.702

10.  The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.

Authors:  Joanna IntHout; John P A Ioannidis; George F Borm
Journal:  BMC Med Res Methodol       Date:  2014-02-18       Impact factor: 4.615

View more
  1 in total

Review 1.  Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.

Authors:  Jonathan R Honegger; Charitha Gowda
Journal:  Curr Opin Infect Dis       Date:  2022-07-15       Impact factor: 4.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.